Fluarix using different strains from those of other vaccines, GSK says

GlaxoSmithKline said recently that its Fluarix, an influenza vaccine, is using different strains from those of other vaccines, in response to the controversial announcement of the Korea Food and Drug Administration and reports of some news media that all of influenza vaccine preparations marketed in Korea contain the same strains.

The company also claimed that developed by GSK in 1992, Fluar...